H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.4% of adults in Yonkers have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Census population 211,569. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Yonkers clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Yonkers storefront.
Fibrin Matrix Therapy Products in Yonkers, NY for clinics & physicians. Fibrin matrix therapy supports wou… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Yonkers is 29.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 12.4% of adults in Yonkers have diagnosed diabetes — 0.4 points above the U.S. 12% figure. New York is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for fibrin matrix therapy, not a walk-in clinic.
National Fibrin Matrix Therapy Products notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Yonkers we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 12.4% of adults in Yonkers have diagnosed diabetes — 0.4 points above the U.S. 12% figure.
We are not going to invent a Yonkers warehouse or a five-star local review. What you get is fibrin matrix therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JK, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.4% of adults — 0.4 points above the U.S. 12% figure. Obesity is 29.3%; arthritis is 23.8%. That is place-level BRFSS modeling, not a clinic census and not a Yonkers trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a New York compliance risk.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
If you operate in New York and another MAC state, say it on the first call. JK will not port 1:1. We would rather split utilization than watch a sister clinic copy Yonkers tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Yonkers, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Yonkers is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Yonkers — 0.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Yonkers. Useful for joint-program math; still needs a diagnosis and privileging.
No Yonkers storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.